Kolexia
Attias David
Cardiologie
Cabinet libéral
Saint-Denis, France
114 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Sténose pathologique Sténose aortique Entorses et foulures Insuffisance mitrale Thrombose Insuffisance tricuspide Maladie des artères coronaires Défaillance cardiaque Amyloïdose

Industries

Abbott
18 collaboration(s)
Dernière en 2023
Novartis
5 collaboration(s)
Dernière en 2022
Vifor
4 collaboration(s)
Dernière en 2021
BMS
2 collaboration(s)
Dernière en 2020

Dernières activités

Tricuspid regurgitation: Frequency, clinical presentation, management and outcome among patients with severe left-sided valvular heart disease in Europe. Insights from the ESC-EORP Valvular Heart Disease II survey.
European journal of heart failure   19 février 2024
MITRA-HR: Multicentre and Randomized Study of MITRACLIP® Transcatheter Mitral Valve Repair in Patients With Severe Primary Mitral Regurgitation Eligible for High-risk Surgery
Essai Clinique (Abbott)   13 février 2024
Clinical and Hemodynamic Outcomes of Balloon-Expandable Mitral Valve-in-Valve Positioning and Asymmetric Deployment: The VIVID Registry.
JACC. Cardiovascular interventions   17 novembre 2023
RACING-HF: RAndomized Controlled Trial of a Multiple INtervention proGram to Decrease Heart Failure Rehospitalization
Essai Clinique (Bayer)   16 juin 2023
Tricuspid regurgitation: Frequency, management and outcome among patients with severe left-sided valvular heart disease in Europe. Insights from the ESC-EORP Valvular Heart Disease II survey
JESFC 2023   01 janvier 2023
Impact of procedural success on clinical outcome after MitraClip: Results from the MITRA-FR trial.
Archives of cardiovascular diseases   29 septembre 2022
Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial.
European heart journal   02 août 2022
Describing mode of death in three major cardiac amyloidosis subtypes to improve management and survival.
Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis   04 février 2022
ADRIFT: Assessment of Dual Antiplatelet Therapy Versus Rivaroxaban In Atrial Fibrillation Patients Treated With Left Atrial Appendage Closure: The Randomized ADRIFT Study
Essai Clinique (Bayer)   20 décembre 2021
Current treatment of symptomatic aortic stenosis in elderly patients: Do risk scores really matter after 80 years of age?
Archives of cardiovascular diseases   29 septembre 2021